NEW YORK, NY / ACCESS Newswire / January 4, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (NYSE:INSP) securities. If you suffered a loss on your Inspire Medical Systems, Inc. investment and would like […]

NEW YORK, NY / ACCESS Newswire / January 4, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE:INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important January 5, 2026 lead plaintiff deadline.

NEW YORK CITY, NY / ACCESS Newswire / January 4, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stride, Inc. (NYSE:LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important January 12, 2026 lead plaintiff deadline. SO WHAT:

AUSTIN, Texas, Jan. 04, 2026 (GLOBE NEWSWIRE) — As B2B companies continue to reassess how they scale demand generation, an increasing number are turning to outsourced digital advertising to maintain performance amid rising costs and resource constraints. Focus Pocus Media, a B2B-focused PPC agency, today announced the introduction of a structured paid media framework designed

Focus Pocus Media Introduces a Paid Media Framework as B2B Companies Increase Digital Advertising Outsourcing As demand for outsourced digital advertising grows, Focus Pocus Media announces a structured paid media approach designed to support faster B2B growth GlobeNewswire January 04, 2026 AUSTIN, Texas, Jan. 04, 2026 (GLOBE NEWSWIRE) — As B2B companies continue to reassess

NEW YORK CITY, NY / ACCESS Newswire / January 4, 2026 / WHY: New York, N.Y., January 4, 2026. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ:TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the "Class Period"), of the important January

NEW YORK CITY, NY / ACCESS Newswire / January 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / January 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Stride, Inc. ("Stride" or the "Company") (NYSE:LRN).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / January 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Firefly Aerospace Inc. ("Firefly" or the "Company") (NASDAQ:FLY) and certain officers.�� The class action, filed in the United States District Court for the Western District of Texas, and docketed under 25-cv-01812,

SINGAPORE and LONDON and NEW YORK, Jan. 04, 2026 (GLOBE NEWSWIRE) — Intelligent Scopes Corp (“ISC”), specializing in state-of-the-art image enhancement and precision AI software solutions for urology and gastroenterology, is pleased to announce that CystoSmart(TM) has received regulatory clearance from Health Sciences Authority (HSA), the National Regulatory Agency for medical products and devices in